AMBER WALKER: Open Payments
NPI 1790468833 · JONESBORO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,205 in 111 payments from 14 companies in 2025. Trend: 2023 $771 · 2024 $1,278 · 2025 $2,205
Food & beverage: $2,205
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $474 |
| GlaxoSmithKline, LLC. | 20 | $350 |
| Regeneron Healthcare Solutions, Inc. | 15 | $267 |
| Insmed, Inc. | 14 | $247 |
| Viatris Specialty LLC | 7 | $143 |
| GENZYME CORPORATION | 13 | $140 |
| Grifols USA, LLC | 6 | $139 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $135 |
| Verona Pharma, Inc. | 5 | $101 |
| Merck Sharp & Dohme LLC | 4 | $94 |
Products named: DUPIXENT, Arikayce, NUCALA, BREZTRI, YUPELRI, Prolastin-C Liquid, GLASSIA, TEZSPIRE.
Industry payments across AR — which companies pay providers there.
